A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT03523442 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03523442
- Sponsor
- Janssen Research & Development, LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-31
- Primary completion
- 2019-07-09
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.